Skip to main content
Erschienen in: Current Heart Failure Reports 3/2015

01.06.2015 | Self-Care and Health Outcomes (T Jaarsma, Section Editor)

Patient-Reported Outcomes in Heart Failure: Existing Measures and Future Uses

verfasst von: Lauren E. Thompson, David B. Bekelman, Larry A. Allen, Pamela N. Peterson

Erschienen in: Current Heart Failure Reports | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Patient-reported outcomes (PROs) are any report obtained directly from a patient about how they feel or function in relation to their health condition and its therapies. Strong support for PROs exists at multiple levels of the health-care community from regulatory boards to clinical researchers. PROs are particularly important in heart failure because it is a common chronic illness marked with acute exacerbations, often requiring hospitalization, and significant symptom burden. Use of PROs to understand patient perspectives will help providers deliver more patient-centered care, and thus improve the quality of care. This review provides a contemporary overview of the current state of PROs in heart failure and suggests future directions and opportunities to advance PRO use to provide more comprehensive care. Advancing PRO measurement along with incorporating longitudinal measures in national databases and local electronic health records will serve to improve patient-centered care for patients with heart failure.
Literatur
1.
Zurück zum Zitat Higgins, Julian PT, ed. Cochrane handbook for systematic reviews of interventions. vol. 5. Chichester: Wiley-Blackwell, 2008. Higgins, Julian PT, ed. Cochrane handbook for systematic reviews of interventions. vol. 5. Chichester: Wiley-Blackwell, 2008.
2.
Zurück zum Zitat Go AS et al. Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation. 2013;127(1):e6–e245.CrossRefPubMed Go AS et al. Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation. 2013;127(1):e6–e245.CrossRefPubMed
3.
Zurück zum Zitat Patrick DL et al. Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health. 2007;10 Suppl 2:S125–37.CrossRefPubMed Patrick DL et al. Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health. 2007;10 Suppl 2:S125–37.CrossRefPubMed
5.
Zurück zum Zitat Fan X, Lee KS, Frazier SK, Lennie TA, Moser DK. Psychometric testing of the Duke Activity Status Index in patients with heart failure. Eur J Cardiovasc Nurs. 2014. doi:10.1177/1474515114523354. Fan X, Lee KS, Frazier SK, Lennie TA, Moser DK. Psychometric testing of the Duke Activity Status Index in patients with heart failure. Eur J Cardiovasc Nurs. 2014. doi:10.​1177/​1474515114523354​.
6.
Zurück zum Zitat Hlatky MA et al. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol. 1989;64(10):651–4.CrossRefPubMed Hlatky MA et al. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol. 1989;64(10):651–4.CrossRefPubMed
8.
Zurück zum Zitat Rector T, Kubo S, Cohn J. Patients’ self-assessment of their congestive heart failure. Part 2: content, reliability and validity of a new measure, the Minnesota Living with Heart Failure Questionnaire. Heart Fail. 1987;3(5):198–209. Rector T, Kubo S, Cohn J. Patients’ self-assessment of their congestive heart failure. Part 2: content, reliability and validity of a new measure, the Minnesota Living with Heart Failure Questionnaire. Heart Fail. 1987;3(5):198–209.
9.
Zurück zum Zitat Green CP et al. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol. 2000;35(5):1245–55.CrossRefPubMed Green CP et al. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol. 2000;35(5):1245–55.CrossRefPubMed
10.
Zurück zum Zitat Ware Jr J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–33.CrossRefPubMed Ware Jr J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–33.CrossRefPubMed
11.
12.
Zurück zum Zitat Derogatis LR et al. The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci. 1974;19(1):1–15.CrossRefPubMed Derogatis LR et al. The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci. 1974;19(1):1–15.CrossRefPubMed
13.
Zurück zum Zitat Cella DF et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11(3):570–9.PubMed Cella DF et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11(3):570–9.PubMed
14.
Zurück zum Zitat Brucker PS et al. General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G). Eval Health Prof. 2005;28(2):192–211.CrossRefPubMed Brucker PS et al. General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G). Eval Health Prof. 2005;28(2):192–211.CrossRefPubMed
15.
Zurück zum Zitat Whoqol S. A cross-cultural study of spirituality, religion, and personal beliefs as components of quality of life. Soc Sci Med. 2006;62:1486–97.CrossRef Whoqol S. A cross-cultural study of spirituality, religion, and personal beliefs as components of quality of life. Soc Sci Med. 2006;62:1486–97.CrossRef
16.
Zurück zum Zitat Bennett SJ et al. Beliefs about medication and dietary compliance in people with heart failure: an instrument development study. Heart Lung. 1997;26(4):273–9.CrossRefPubMed Bennett SJ et al. Beliefs about medication and dietary compliance in people with heart failure: an instrument development study. Heart Lung. 1997;26(4):273–9.CrossRefPubMed
17.
Zurück zum Zitat Bennett SJ et al. Reliability and validity of the compliance belief scales among patients with heart failure. Heart Lung. 2001;30(3):177–85.CrossRefPubMed Bennett SJ et al. Reliability and validity of the compliance belief scales among patients with heart failure. Heart Lung. 2001;30(3):177–85.CrossRefPubMed
18.
Zurück zum Zitat Bentley B et al. Demonstration of psychometric soundness of the Dietary Sodium Restriction Questionnaire in patients with heart failure. Heart Lung. 2009;38(2):121–8.CrossRefPubMed Bentley B et al. Demonstration of psychometric soundness of the Dietary Sodium Restriction Questionnaire in patients with heart failure. Heart Lung. 2009;38(2):121–8.CrossRefPubMed
19.
Zurück zum Zitat Lennie TA et al. Relationship of heart failure patients’ knowledge, perceived barriers, and attitudes regarding low-sodium diet recommendations to adherence. Prog Cardiovasc Nurs. 2008;23(1):6–11.CrossRefPubMed Lennie TA et al. Relationship of heart failure patients’ knowledge, perceived barriers, and attitudes regarding low-sodium diet recommendations to adherence. Prog Cardiovasc Nurs. 2008;23(1):6–11.CrossRefPubMed
20.
Zurück zum Zitat Riegel B, Carlson B, Glaser D. Development and testing of a clinical tool measuring self-management of heart failure. Heart Lung J Acute Crit Care. 2000;29(1):4–15.CrossRef Riegel B, Carlson B, Glaser D. Development and testing of a clinical tool measuring self-management of heart failure. Heart Lung J Acute Crit Care. 2000;29(1):4–15.CrossRef
21.
Zurück zum Zitat Baker DW et al. A telephone survey to measure communication, education, self-management, and health status for patients with heart failure: the Improving Chronic Illness Care Evaluation (ICICE). J Card Fail. 2005;11(1):36–42.CrossRefPubMed Baker DW et al. A telephone survey to measure communication, education, self-management, and health status for patients with heart failure: the Improving Chronic Illness Care Evaluation (ICICE). J Card Fail. 2005;11(1):36–42.CrossRefPubMed
22.
Zurück zum Zitat Baker DW et al. Differences in education, knowledge, self-management activities, and health outcomes for patients with heart failure cared for under the chronic disease model: the improving chronic illness care evaluation. J Card Fail. 2005;11(6):405–13.CrossRefPubMed Baker DW et al. Differences in education, knowledge, self-management activities, and health outcomes for patients with heart failure cared for under the chronic disease model: the improving chronic illness care evaluation. J Card Fail. 2005;11(6):405–13.CrossRefPubMed
23.
Zurück zum Zitat Jaarsma T et al. The European Heart Failure Self-care Behaviour scale revised into a nine-item scale (EHFScB-9): a reliable and valid international instrument. Eur J Heart Fail. 2009;11(1):99–105.CrossRefPubMed Jaarsma T et al. The European Heart Failure Self-care Behaviour scale revised into a nine-item scale (EHFScB-9): a reliable and valid international instrument. Eur J Heart Fail. 2009;11(1):99–105.CrossRefPubMed
24.
Zurück zum Zitat Brehaut JC et al. Validation of a decision regret scale. Med Decis Mak. 2003;23(4):281–92.CrossRef Brehaut JC et al. Validation of a decision regret scale. Med Decis Mak. 2003;23(4):281–92.CrossRef
25.
Zurück zum Zitat Chew LD, Bradley KA, Boyko EJ. Brief questions to identify patients with inadequate health literacy. Fam Med. 2004;36(8):588–94.PubMed Chew LD, Bradley KA, Boyko EJ. Brief questions to identify patients with inadequate health literacy. Fam Med. 2004;36(8):588–94.PubMed
26.
27.
Zurück zum Zitat Rumsfeld JS. Health status and clinical practice: when will they meet? Circulation. 2002;106(1):5–7.CrossRefPubMed Rumsfeld JS. Health status and clinical practice: when will they meet? Circulation. 2002;106(1):5–7.CrossRefPubMed
28.
Zurück zum Zitat Spertus JA et al. Expanding the outcomes in clinical trials of heart failure: the quality of life and economic components of EPHESUS (EPlerenone’s neuroHormonal efficacy and survival study). Am Heart J. 2002;143(4):636–42.CrossRefPubMed Spertus JA et al. Expanding the outcomes in clinical trials of heart failure: the quality of life and economic components of EPHESUS (EPlerenone’s neuroHormonal efficacy and survival study). Am Heart J. 2002;143(4):636–42.CrossRefPubMed
29.••
Zurück zum Zitat Rumsfeld JS et al. Cardiovascular health: the importance of measuring patient-reported health status: a scientific statement from the American Heart Association. Circulation. 2013;127(22):2233–49. Comprehensive review of patient-reported health status measures, with emphasis on future uses and implementation.CrossRefPubMed Rumsfeld JS et al. Cardiovascular health: the importance of measuring patient-reported health status: a scientific statement from the American Heart Association. Circulation. 2013;127(22):2233–49. Comprehensive review of patient-reported health status measures, with emphasis on future uses and implementation.CrossRefPubMed
30.
Zurück zum Zitat Calkins DR et al. Failure of physicians to recognize functional disability in ambulatory patients. Ann Intern Med. 1991;114(6):451–4.CrossRefPubMed Calkins DR et al. Failure of physicians to recognize functional disability in ambulatory patients. Ann Intern Med. 1991;114(6):451–4.CrossRefPubMed
31.
Zurück zum Zitat Heidenreich PA et al. Health status identifies heart failure outpatients at risk for hospitalization or death. J Am Coll Cardiol. 2006;47(4):752–6.CrossRefPubMed Heidenreich PA et al. Health status identifies heart failure outpatients at risk for hospitalization or death. J Am Coll Cardiol. 2006;47(4):752–6.CrossRefPubMed
32.
Zurück zum Zitat Mommersteeg PMC et al. Health status as a risk factor in cardiovascular disease: a systematic review of current evidence. Am Heart J. 2009;157(2):208–18.CrossRefPubMed Mommersteeg PMC et al. Health status as a risk factor in cardiovascular disease: a systematic review of current evidence. Am Heart J. 2009;157(2):208–18.CrossRefPubMed
33.
Zurück zum Zitat Chan PS et al. Patient health status and costs in heart failure: insights from the eplerenone post–acute myocardial infarction heart failure efficacy and survival study (EPHESUS). Circulation. 2009;119(3):398–407.CrossRefPubMed Chan PS et al. Patient health status and costs in heart failure: insights from the eplerenone post–acute myocardial infarction heart failure efficacy and survival study (EPHESUS). Circulation. 2009;119(3):398–407.CrossRefPubMed
34.
Zurück zum Zitat Rector TS et al. Use of the living with heart failure questionnaire to ascertain patients’ perspectives on improvement in quality of life versus risk of drug-induced death. J Card Fail. 1995;1(3):201–6.CrossRefPubMed Rector TS et al. Use of the living with heart failure questionnaire to ascertain patients’ perspectives on improvement in quality of life versus risk of drug-induced death. J Card Fail. 1995;1(3):201–6.CrossRefPubMed
35.
Zurück zum Zitat Tsevat J et al. Health values of hospitalized patients 80 years or older. HELP Investigators. Hospitalized elderly longitudinal project. JAMA. 1998;279(5):371–5.CrossRefPubMed Tsevat J et al. Health values of hospitalized patients 80 years or older. HELP Investigators. Hospitalized elderly longitudinal project. JAMA. 1998;279(5):371–5.CrossRefPubMed
36.
Zurück zum Zitat Lewis EF et al. Preferences for quality of life or survival expressed by patients with heart failure. J Heart Lung Transplant. 2001;20(9):1016–24.CrossRefPubMed Lewis EF et al. Preferences for quality of life or survival expressed by patients with heart failure. J Heart Lung Transplant. 2001;20(9):1016–24.CrossRefPubMed
37.
Zurück zum Zitat Brunner-La Rocca HP et al. End-of-life preferences of elderly patients with chronic heart failure. Eur Heart J. 2012;33(6):752–9.CrossRefPubMed Brunner-La Rocca HP et al. End-of-life preferences of elderly patients with chronic heart failure. Eur Heart J. 2012;33(6):752–9.CrossRefPubMed
38.
Zurück zum Zitat Kraai IH et al. Preferences of heart failure patients in daily clinical practice: quality of life or longevity? Eur J Heart Fail. 2013;15(10):1113–21.CrossRefPubMed Kraai IH et al. Preferences of heart failure patients in daily clinical practice: quality of life or longevity? Eur J Heart Fail. 2013;15(10):1113–21.CrossRefPubMed
39.
Zurück zum Zitat Yancy CW et al. 2013 ACCF/AHA Guideline for the Management of Heart Failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128(16):e240–327.CrossRefPubMed Yancy CW et al. 2013 ACCF/AHA Guideline for the Management of Heart Failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128(16):e240–327.CrossRefPubMed
41.
Zurück zum Zitat Members WC et al. ACCF/AHA/AMA-PCPI 2011 Performance measures for adults with heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association–Physician Consortium for Performance Improvement. Circulation. 2012;125(19):2382–401.CrossRef Members WC et al. ACCF/AHA/AMA-PCPI 2011 Performance measures for adults with heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association–Physician Consortium for Performance Improvement. Circulation. 2012;125(19):2382–401.CrossRef
42.
Zurück zum Zitat Anker SD et al. The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials. Eur Heart J. 2014;35(30):2001–9.CrossRefPubMed Anker SD et al. The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials. Eur Heart J. 2014;35(30):2001–9.CrossRefPubMed
43.••
Zurück zum Zitat Frank L et al. The PCORI perspective on patient-centered outcomes research. JAMA. 2014;312(15):1513–4. Explanation of PCORI goals for the future as well as a reivew of current grant selection process.CrossRefPubMed Frank L et al. The PCORI perspective on patient-centered outcomes research. JAMA. 2014;312(15):1513–4. Explanation of PCORI goals for the future as well as a reivew of current grant selection process.CrossRefPubMed
45.
Zurück zum Zitat Institute of Medicine, Committee on Quality of Health Care in America. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, D.C.: National Academy Press; 2001. Institute of Medicine, Committee on Quality of Health Care in America. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, D.C.: National Academy Press; 2001.
46.
Zurück zum Zitat Zannad F et al. Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document. Eur J Heart Fail. 2013;15(10):1082–94.CrossRefPubMed Zannad F et al. Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document. Eur J Heart Fail. 2013;15(10):1082–94.CrossRefPubMed
47.
Zurück zum Zitat Eton DT et al. A systematic review of patient-reported measures of burden of treatment in three chronic diseases. Patient Relat Outcome Meas. 2013;4:7–20.CrossRefPubMedCentralPubMed Eton DT et al. A systematic review of patient-reported measures of burden of treatment in three chronic diseases. Patient Relat Outcome Meas. 2013;4:7–20.CrossRefPubMedCentralPubMed
48.
Zurück zum Zitat Spertus JA. Evolving applications for patient-centered health status measures. Circulation. 2008;118(20):2103–10.CrossRefPubMed Spertus JA. Evolving applications for patient-centered health status measures. Circulation. 2008;118(20):2103–10.CrossRefPubMed
49.
Zurück zum Zitat US Department of Health and Human Services, FDA. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health and Quality of Life Outcomes. 2006;4:79. doi:10.1186/1477-7525-4-79. US Department of Health and Human Services, FDA. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health and Quality of Life Outcomes. 2006;4:79. doi:10.​1186/​1477-7525-4-79.
50.
Zurück zum Zitat Dyer MT et al. A review of health utilities using the EQ-5D in studies of cardiovascular disease. Health Qual Life Outcomes. 2010;8(13):1–12. Dyer MT et al. A review of health utilities using the EQ-5D in studies of cardiovascular disease. Health Qual Life Outcomes. 2010;8(13):1–12.
52.
Zurück zum Zitat Nowels D et al. Validation of the EQ-5D quality of life instrument in patients after myocardial infarction. Qual Life Res. 2005;14(1):95–105.CrossRefPubMed Nowels D et al. Validation of the EQ-5D quality of life instrument in patients after myocardial infarction. Qual Life Res. 2005;14(1):95–105.CrossRefPubMed
53.
Zurück zum Zitat Anker SD et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009;361(25):2436–48.CrossRefPubMed Anker SD et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009;361(25):2436–48.CrossRefPubMed
54.
Zurück zum Zitat Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Am Heart J. 1992;124(4):1017–25.CrossRefPubMed Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Am Heart J. 1992;124(4):1017–25.CrossRefPubMed
55.
Zurück zum Zitat Guyatt GH et al. Development and testing of a new measure of health status for clinical trials in heart failure. J Gen Intern Med. 1989;4(2):101–7.CrossRefPubMed Guyatt GH et al. Development and testing of a new measure of health status for clinical trials in heart failure. J Gen Intern Med. 1989;4(2):101–7.CrossRefPubMed
56.
Zurück zum Zitat Wiklund I et al. Self-assessment of quality of life in severe heart failure: an instrument for clinical use. Scand J Psychol. 1987;28(3):220–5.CrossRefPubMed Wiklund I et al. Self-assessment of quality of life in severe heart failure: an instrument for clinical use. Scand J Psychol. 1987;28(3):220–5.CrossRefPubMed
57.
Zurück zum Zitat Zambroski CH et al. Impact of symptom prevalence and symptom burden on quality of life in patients with heart failure. Eur J Cardiovasc Nurs. 2005;4(3):198–206.CrossRefPubMed Zambroski CH et al. Impact of symptom prevalence and symptom burden on quality of life in patients with heart failure. Eur J Cardiovasc Nurs. 2005;4(3):198–206.CrossRefPubMed
58.
Zurück zum Zitat Hawthorne G et al. Deriving utility scores from the SF-36 health instrument using Rasch analysis. Qual Life Res. 2008;17(9):1183–93.CrossRefPubMed Hawthorne G et al. Deriving utility scores from the SF-36 health instrument using Rasch analysis. Qual Life Res. 2008;17(9):1183–93.CrossRefPubMed
59.
Zurück zum Zitat Cella D et al. The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. J Clin Epidemiol. 2010;63(11):1179–94.CrossRefPubMedCentralPubMed Cella D et al. The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. J Clin Epidemiol. 2010;63(11):1179–94.CrossRefPubMedCentralPubMed
60.
Zurück zum Zitat Raphael C et al. Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart. 2007;93(4):476–82.CrossRefPubMedCentralPubMed Raphael C et al. Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart. 2007;93(4):476–82.CrossRefPubMedCentralPubMed
61.
Zurück zum Zitat Tate 3rd CW et al. Quality of life and prognosis in heart failure: results of the Beta-Blocker Evaluation of Survival Trial (BEST). J Card Fail. 2007;13(9):732–7.CrossRefPubMed Tate 3rd CW et al. Quality of life and prognosis in heart failure: results of the Beta-Blocker Evaluation of Survival Trial (BEST). J Card Fail. 2007;13(9):732–7.CrossRefPubMed
62.
Zurück zum Zitat Flynn KE et al. Relationships between changes in patient-reported health status and functional capacity in outpatients with heart failure. Am Heart J. 2012;163(1):88.e3–94.e3.CrossRef Flynn KE et al. Relationships between changes in patient-reported health status and functional capacity in outpatients with heart failure. Am Heart J. 2012;163(1):88.e3–94.e3.CrossRef
63.
Zurück zum Zitat Kosiborod M et al. Identifying heart failure patients at high risk for near-term cardiovascular events with serial health status assessments. Circulation. 2007;115(15):1975–81.CrossRefPubMed Kosiborod M et al. Identifying heart failure patients at high risk for near-term cardiovascular events with serial health status assessments. Circulation. 2007;115(15):1975–81.CrossRefPubMed
64.
Zurück zum Zitat Spertus J et al. Monitoring clinical changes in patients with heart failure: a comparison of methods. Am Heart J. 2005;150(4):707–15.CrossRefPubMed Spertus J et al. Monitoring clinical changes in patients with heart failure: a comparison of methods. Am Heart J. 2005;150(4):707–15.CrossRefPubMed
66.
Zurück zum Zitat Luther SA et al. The relationship between B-type natriuretic peptide and health status in patients with heart failure. J Card Fail. 2005;11(6):414–21.CrossRefPubMed Luther SA et al. The relationship between B-type natriuretic peptide and health status in patients with heart failure. J Card Fail. 2005;11(6):414–21.CrossRefPubMed
67.
Zurück zum Zitat Design of the Beta-Blocker Evaluation Survival Trial (BEST). The BEST Steering Committee. American Journal of Cardiology. 1995;75(17):1220–3. Design of the Beta-Blocker Evaluation Survival Trial (BEST). The BEST Steering Committee. American Journal of Cardiology. 1995;75(17):1220–3.
68.
69.
Zurück zum Zitat Schiffer AA et al. Health status in patients treated with cardiac resynchronization therapy: modulating effects of personality. Pacing Clin Electrophysiol. 2008;31(1):28–37.CrossRefPubMed Schiffer AA et al. Health status in patients treated with cardiac resynchronization therapy: modulating effects of personality. Pacing Clin Electrophysiol. 2008;31(1):28–37.CrossRefPubMed
70.
Zurück zum Zitat Mark DB et al. Quality-of-life outcomes with coronary artery bypass graft surgery in ischemic left ventricular dysfunction: a randomized trial. Ann Intern Med. 2014;161(6):392–9.CrossRefPubMedCentralPubMed Mark DB et al. Quality-of-life outcomes with coronary artery bypass graft surgery in ischemic left ventricular dysfunction: a randomized trial. Ann Intern Med. 2014;161(6):392–9.CrossRefPubMedCentralPubMed
71.
Zurück zum Zitat Nesbitt T et al. Correlates of quality of life in rural heart failure patients. Circ Heart Fail. 2014;7:882–7.CrossRefPubMed Nesbitt T et al. Correlates of quality of life in rural heart failure patients. Circ Heart Fail. 2014;7:882–7.CrossRefPubMed
72.
Zurück zum Zitat Edelman JJ et al. Percutaneous mitral valve repair in a high-risk Australian series. Heart Lung Circ. 2014;23(6):520–6.CrossRefPubMed Edelman JJ et al. Percutaneous mitral valve repair in a high-risk Australian series. Heart Lung Circ. 2014;23(6):520–6.CrossRefPubMed
73.
Zurück zum Zitat Filippatos G et al. Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial. Eur J Heart Fail. 2013;15(11):1267–76.CrossRefPubMedCentralPubMed Filippatos G et al. Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial. Eur J Heart Fail. 2013;15(11):1267–76.CrossRefPubMedCentralPubMed
74.
Zurück zum Zitat Kerrigan DJ, Williams CT, Ehrman JK, Saval MA, Bronsteen K, Schairer JR, Swaffer M, Brawner CA, Lanfear DE, Selektor Y, Velez M, Tita C, Keteyian SJ. Cardiac rehabilitation improves functional capacity and patient-reported health status in patients with continuous-flow left ventricular assist devices: the Rehab-VAD randomized controlled trial. JACC Heart Failure. 2014;2(6):653–9. Kerrigan DJ, Williams CT, Ehrman JK, Saval MA, Bronsteen K, Schairer JR, Swaffer M, Brawner CA, Lanfear DE, Selektor Y, Velez M, Tita C, Keteyian SJ. Cardiac rehabilitation improves functional capacity and patient-reported health status in patients with continuous-flow left ventricular assist devices: the Rehab-VAD randomized controlled trial. JACC Heart Failure. 2014;2(6):653–9.
75.
Zurück zum Zitat Costanzo MR et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol. 2007;49(6):675–83.CrossRefPubMed Costanzo MR et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol. 2007;49(6):675–83.CrossRefPubMed
76.
Zurück zum Zitat St John Sutton MG et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation. 2003;107(15):1985–90.CrossRefPubMed St John Sutton MG et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation. 2003;107(15):1985–90.CrossRefPubMed
77.
Zurück zum Zitat Xiong GL et al. Health status and depression remission in patients with chronic heart failure: patient-reported outcomes from the SADHART-CHF trial. Circ Heart Fail. 2012;5(6):688–92.CrossRefPubMedCentralPubMed Xiong GL et al. Health status and depression remission in patients with chronic heart failure: patient-reported outcomes from the SADHART-CHF trial. Circ Heart Fail. 2012;5(6):688–92.CrossRefPubMedCentralPubMed
78.
Zurück zum Zitat Anand IS, Florea VG, Fisher L. Surrogate end points in heart failure. J Am Coll Cardiol. 2002;39(9):1414–21.CrossRefPubMed Anand IS, Florea VG, Fisher L. Surrogate end points in heart failure. J Am Coll Cardiol. 2002;39(9):1414–21.CrossRefPubMed
79.
Zurück zum Zitat McMurray JJV et al. Angiotensin–neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371(11):993–1004.CrossRefPubMed McMurray JJV et al. Angiotensin–neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371(11):993–1004.CrossRefPubMed
80.
Zurück zum Zitat Reynolds MR et al. Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation. 2011;124(18):1964–72.CrossRefPubMed Reynolds MR et al. Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation. 2011;124(18):1964–72.CrossRefPubMed
81.
Zurück zum Zitat Bekelman DB et al. Patient-centered disease management (PCDM) for heart failure: study protocol for a randomised controlled trial. BMC Cardiovasc Disord. 2013;13:49.CrossRefPubMedCentralPubMed Bekelman DB et al. Patient-centered disease management (PCDM) for heart failure: study protocol for a randomised controlled trial. BMC Cardiovasc Disord. 2013;13:49.CrossRefPubMedCentralPubMed
82.
Zurück zum Zitat Allen LA et al. Identifying patients hospitalized with heart failure at risk for unfavorable future quality of life. Circ Cardiovasc Qual Outcomes. 2011;4(4):389–98.CrossRefPubMedCentralPubMed Allen LA et al. Identifying patients hospitalized with heart failure at risk for unfavorable future quality of life. Circ Cardiovasc Qual Outcomes. 2011;4(4):389–98.CrossRefPubMedCentralPubMed
83.
Zurück zum Zitat Conard MW et al. Patient-reported economic burden and the health status of heart failure patients. J Card Fail. 2006;12(5):369–74.CrossRefPubMed Conard MW et al. Patient-reported economic burden and the health status of heart failure patients. J Card Fail. 2006;12(5):369–74.CrossRefPubMed
84.
Zurück zum Zitat Sandau KE et al. A conceptual definition of quality of life with a left ventricular assist device: results from a qualitative study. Heart Lung. 2014;43(1):32–40.CrossRefPubMed Sandau KE et al. A conceptual definition of quality of life with a left ventricular assist device: results from a qualitative study. Heart Lung. 2014;43(1):32–40.CrossRefPubMed
85.
Zurück zum Zitat Modica M, Ferratini M, Torri A, Oliva F, Martinelli L, De Maria R, et al. Quality of Life and Emotional Distress Early After Left Ventricular Assist Device Implant: A Mixed-Method Study. Artificial Organs. 2014. doi:10.1111/aor.12362. Modica M, Ferratini M, Torri A, Oliva F, Martinelli L, De Maria R, et al. Quality of Life and Emotional Distress Early After Left Ventricular Assist Device Implant: A Mixed-Method Study. Artificial Organs. 2014. doi:10.​1111/​aor.​12362.
86.
Zurück zum Zitat McIlvennan CK et al. Decision making for destination therapy left ventricular assist devices: “there was no choice” versus “I thought about it an awful lot”. Circ Cardiovasc Qual Outcomes. 2014;7(3):374–80.CrossRefPubMed McIlvennan CK et al. Decision making for destination therapy left ventricular assist devices: “there was no choice” versus “I thought about it an awful lot”. Circ Cardiovasc Qual Outcomes. 2014;7(3):374–80.CrossRefPubMed
87.
Zurück zum Zitat McIlvennan CK, Allen LA. To DT or not to DT, that is the question: working toward a comprehensive, patient-centered perspective on left ventricular assist device for destination therapy. Circ Cardiovasc Qual Outcomes. 2014;7(1):13–4.CrossRefPubMed McIlvennan CK, Allen LA. To DT or not to DT, that is the question: working toward a comprehensive, patient-centered perspective on left ventricular assist device for destination therapy. Circ Cardiovasc Qual Outcomes. 2014;7(1):13–4.CrossRefPubMed
88.
Zurück zum Zitat Brouwers C et al. Patient-reported outcomes in left ventricular assist device therapy: a systematic review and recommendations for clinical research and practice. Circ Heart Fail. 2011;4(6):714–23.CrossRefPubMed Brouwers C et al. Patient-reported outcomes in left ventricular assist device therapy: a systematic review and recommendations for clinical research and practice. Circ Heart Fail. 2011;4(6):714–23.CrossRefPubMed
91.
93.
Zurück zum Zitat Macabasco-O’Connell A et al. Relationship between literacy, knowledge, self-care behaviors, and heart failure-related quality of life among patients with heart failure. J Gen Intern Med. 2011;26(9):979–86.CrossRefPubMedCentralPubMed Macabasco-O’Connell A et al. Relationship between literacy, knowledge, self-care behaviors, and heart failure-related quality of life among patients with heart failure. J Gen Intern Med. 2011;26(9):979–86.CrossRefPubMedCentralPubMed
94.
Zurück zum Zitat Peterson PN et al. Health literacy and outcomes among patients with heart failure. JAMA. 2011;305(16):1695–701.CrossRefPubMed Peterson PN et al. Health literacy and outcomes among patients with heart failure. JAMA. 2011;305(16):1695–701.CrossRefPubMed
95.
Zurück zum Zitat Joyce KE et al. Incorporating the patient perspective: a critical review of clinical practice guidelines for implantable cardioverter defibrillator therapy. J Interv Card Electrophysiol. 2013;36(2):185–97.CrossRefPubMed Joyce KE et al. Incorporating the patient perspective: a critical review of clinical practice guidelines for implantable cardioverter defibrillator therapy. J Interv Card Electrophysiol. 2013;36(2):185–97.CrossRefPubMed
96.
Zurück zum Zitat Humphrey L et al. The Caregiver Burden Questionnaire for Heart Failure (CBQ-HF): face and content validity. Health Qual Life Outcomes. 2013;11(1):84.CrossRefPubMedCentralPubMed Humphrey L et al. The Caregiver Burden Questionnaire for Heart Failure (CBQ-HF): face and content validity. Health Qual Life Outcomes. 2013;11(1):84.CrossRefPubMedCentralPubMed
97.
Zurück zum Zitat Luttik ML et al. The objective burden in partners of heart failure patients; development and initial validation of the Dutch Objective Burden Inventory. Eur J Cardiovasc Nurs. 2008;7(1):3–9.CrossRefPubMed Luttik ML et al. The objective burden in partners of heart failure patients; development and initial validation of the Dutch Objective Burden Inventory. Eur J Cardiovasc Nurs. 2008;7(1):3–9.CrossRefPubMed
98.
Zurück zum Zitat Vellone E et al. Validity and reliability of the caregiver contribution to self-care of heart failure index. J Cardiovasc Nurs. 2013;28(3):245–55.CrossRefPubMed Vellone E et al. Validity and reliability of the caregiver contribution to self-care of heart failure index. J Cardiovasc Nurs. 2013;28(3):245–55.CrossRefPubMed
99.
Zurück zum Zitat Burke RE et al. Caregivers’ perceived roles in caring for patients with heart failure: what do clinicians need to know? J Card Fail. 2014;20(10):731–8.CrossRefPubMed Burke RE et al. Caregivers’ perceived roles in caring for patients with heart failure: what do clinicians need to know? J Card Fail. 2014;20(10):731–8.CrossRefPubMed
Metadaten
Titel
Patient-Reported Outcomes in Heart Failure: Existing Measures and Future Uses
verfasst von
Lauren E. Thompson
David B. Bekelman
Larry A. Allen
Pamela N. Peterson
Publikationsdatum
01.06.2015
Verlag
Springer US
Erschienen in
Current Heart Failure Reports / Ausgabe 3/2015
Print ISSN: 1546-9530
Elektronische ISSN: 1546-9549
DOI
https://doi.org/10.1007/s11897-015-0253-9

Weitere Artikel der Ausgabe 3/2015

Current Heart Failure Reports 3/2015 Zur Ausgabe

Nonpharmacologic Therapy: Surgery, Ventricular Assist Devices, Biventricular Pacing, and Exercise (AK Hasan, Section Editor)

Is There a Role for Invasive Hemodynamic Monitoring in Acute Heart Failure Management?

Pathophysiology: Neuroendocrine, Vascular, and Metabolic Factors (SD Katz, Section Editor)

Sarcopenic Obesity and the Pathogenesis of Exercise Intolerance in Heart Failure with Preserved Ejection Fraction

Self-Care and Health outcomes (T Jaarsma, Section Editor)

Tailoring of Self-Management Interventions in Patients With Heart Failure

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.